Expansion Therapeutics competitors

John Fowler is a Managing Director at Montebello Holdings, Co-Founder and CEO at Kezar Life Sciences Inc, and Board Member at Kezar Life Sciences Inc and is based in South San Francisco, California. He has worked as Management Consultant at William Kent International, CEO at Aero Logistics, and Managing Director at Montebello Capital. John studied at Stanford Graduate School of Business between 1998 and 2000 and Stanford University between 1989 and 1993.

Simon Xi is the Co-Founder and Chief Executive Officer of Rgenta. He has 20 years of drug discovery experience in top pharmaceutical companies and academic institutes. Simon helped conceptualize the initial scientific strategy for Rgenta and has led the development of the discovery platform since its launch. Prior to Rgenta, Simon was the head of the genomics and compbio group at Abbvie foundational neuroscience center where he established the genomics platform and compbio function for target discovery and validation. Before Rgenta, Simon was an accomplished scientist and group leader at Pfizer with increasing responsibilities. During his time at Pfizer, Simon has led multiple novel therapeutics targets into the discovery portfolio and established close collaborations with academic institutions. Simon co-authored more than 30 research publications and is currently an adjunct faculty at Brandeis University and a principal investigator in the GTEx Consortium.

Jim Burns is a Chief Executive Officer at Locana and is based in Boston, Massachusetts. He has worked as Head of R&D at SANOFI, Senior VP:Biosurgery Product Dev at Genzyme Surgical Products Corp, and President and CEO at CASEBIA THERAPEUTICS LLP. Jim attended Purdue University between 1973 and 1977, University of Illinois Urbana Champaign, and University of Illinois Chicago between 1978 and 1984.